‹ All Posts
Akshay Patel

21st Nov · SEBI-Registered Analyst

MAXHEALTH
announced robust Q2 FY26 results, with revenue up 21% to ₹2,692 crore and net profit soaring 74.34% to ₹491.30 crore. The company's EBITDA margin improved to 26.93%. Expansion initiatives include new towers at Max Mohali, Nanavati-Max, and Max Smart, adding significant bed capacity. The company expects to benefit from CGHS price revisions, potentially adding over ₹200 crore to revenue once fully implemented. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

#StockInNews
814 likes·55 comments